New data demonstrate the actionability of clonoSEQ for tailoring treatment decisions in patients with MCL, CLL, MM and ALL Studies...
Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity...
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical...
Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing HNSCC ongoing with clinical data update planned for 2025 Petosemtamab...
Research explores treatment patterns and health outcomes to inform and improve patient careBOSTON & SAN DIEGO--(BUSINESS WIRE)--Ontada®, a McKesson business...
NEW YORK, Dec. 6, 2024 /PRNewswire/ -- This December, Mount Sinai Hospital's Department of Urology, under the leadership of Ash...
STOCKHOLM, Dec. 6, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that discrete proton arc optimization in...
Up to $1.9 million up front with up to an additional $2.7 million of potential aggregate gross proceeds upon the...
MIAMI, Dec. 6, 2024 /PRNewswire/ -- eMerge Americas, the premier global technology conference and expo shaping the future of tech, is...
The study is one of five clinical efforts - three IIT proof-of-concept studies and two Phase 2 studies - of...
JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the...
OSAKA, Japan and MONTREAL , Dec. 5, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") announced that...
RALEIGH, N.C., Dec. 5, 2024 /PRNewswire/ -- InvestiQuant, a leading provider of AI-driven, alternative investment solutions, proudly announces the success...
NEW YORK, Dec. 5, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global eclinical solutions...
Lunit and Volpara revealed a unified Ecosystem at RSNA 2024, featuring AI-powered cancer risk prediction, autonomous report generation, and innovations...
Data confirm previous results showing that ProSense® cryoablation is highly effective for kidney tumors < 3 cm and a safe...
Theator's advanced AI technology sets a new standard in surgical safety, outperforming competitors in the SAGES CVS Challenge and showcasing...
Vevo's Mosaic platform is the first to make single-cell measurement of drug action across heterogeneous patients scalable The Tahoe-100M dataset,...
Canalevia®-CA1 is a canine-specific formulation of crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri treeCrofelemer, the...
Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion LeadersCompany committed to addressing the most aggressive type of...